Hello @harsh.beria93,

Congratulations on the great performance and detailed analysis.

As you are largely invested in Small caps, Nifty might not be the best benchmark. You can create a portfolio market cap weighted benchmark : 60% * BSE Small Cap+ 20%* CNX Midcap + 20% * Nifty etc. based on allocations.

Another option is to compare with the leading PMS’ with consistent long term compounding. Your true opportunity cost lies there as you are unlikely to simply pick a Nifty index fund if not investing on your own.

I use a average returns index from 3 funds

1. SageOne Small Cap
2. @aveekmitra’s Aveksat Equity
3. @ayushmit’s Mittal Analytics

Once again Congratulations for your great research and coverage across such broader areas with ever increasing circle of competence.

Promoters selling in the December month, offloaded 4-5%.

Hello

Why is the slowdown in lending being considered as a permanent thing? Are we assuming that RBI will continue to discourage BNPL as a category of lending in the country? May be fellow boarders can share some policy document which claims so.

I do not see any reason for Paytm not to continue to lead in the BNPL category. And in my opinion there does not seem to be any long term reason for BNPL to not be a part of the overall lending mix in the country.

Correct me if I’m wrong team….
All said and done if Aster GCC business gets sold – that basically means we lose our cash cow
Yes we’d receive cash in exchange, but the cash would not justify the current valuations.

Aster would have deploy this cash and then build up the same level of operations it had back in GCC and the chances of that to happen is very unlikely.
GCC business was very much a monopoly because of few hospitals and very high insurance penetration. In India you have significant competition with low insurance penetration.

Hence this deal is really unfavourable to retail investors.
Let me know what you think? Am I missing something?